
Market Cap
$532.43M
24h Volume
$181.26M
Circulating
100M INJ
All-Time High
$52.62
Market Cap
$532.43M
Volume (24h)
$181.26M
Circulating Supply
100M INJ
Max Supply
N/A
1 INJ = $5.32
| All-Time High | $52.62 (March 14, 2024) |
| All-Time Low | $0.657401 (November 3, 2020) |
Injective (INJ) is a Layer-1 blockchain built specifically for finance. Eric Chen and Albert Chon founded the project in 2018, with early backing from Binance Labs and Pantera, and the mainnet went live in November 2021. The chain itself ships with a native order book, a derivatives engine, oracle modules, and bridges, so the things most networks leave to dApps are part of the protocol on Injective.
INJ is the native token. The supply is capped at 100 million. Issuance is inflationary by default to pay validators and stakers, but a weekly burn auction takes 60% of all dApp protocol fees and pulls INJ out of circulation. In practice, that combination has made INJ deflationary in most active weeks. The token is also used for staking, governance votes, fees, and as collateral in the trading modules.
INJ trades against USD, USDT, and BTC on every Tier-1 venue. The INJ/USD figure on this page is a volume-weighted aggregate from the spot exchanges with the deepest order books, refreshed every 60 seconds.
What tends to move INJ in any given week:
The price card above streams live data; the analysis below uses the levels at page load.
Injective is a Cosmos SDK chain running CometBFT consensus. Block time is around 0.65 seconds and the network has been benchmarked above 25,000 transactions per second. The architecture is sovereign, the same design philosophy as the rest of the Cosmos ecosystem, but Injective is shaped specifically for trading rather than general-purpose smart contracts.
▼ +89.86% from ATH
| Trade → |
| DigiFinex | INJ/USDT | $5.33 | Trade → |
| Coinbase Exchange | INJ/USD | $5.32 | Trade → |
The big difference from most other L1s is what lives at the protocol level. Injective ships a central limit order book directly in the chain logic, plus modules for spot markets, perpetual futures, binary options, and cross-chain bridges. dApps plug into shared liquidity instead of bootstrapping their own AMM pools. That is why a derivatives platform on Injective starts with deep books on day one rather than asking market makers to seed pools from scratch.
On the developer side, Injective added native EVM (sometimes called inEVM) in 2024. Solidity contracts run alongside the existing CosmWasm environment and share the order book module. A native SVM integration is in development, which would let teams port code from Solana directly. IBC connects Injective to the wider Cosmos network; standard bridges connect it to Ethereum, Solana, and major L2s.
The burn auction is the part of Injective tokenomics that gets the most attention. Every week, 60% of the protocol fees collected by all dApps on the chain go into a basket. Anyone can bid INJ for that basket. The highest bid wins the basket, and the entire INJ bid amount is burned. Cumulative INJ burned through this mechanism runs into the millions of tokens.
A few mechanics worth knowing:
The practical result is that INJ behaves like a deflationary asset whenever the chain is active. Quiet weeks lean inflationary because issuance still pays validators; busy weeks burn enough INJ to net out negative supply growth. Holders tracking real yield should look at the staking APR alongside the rolling four-week burn rate, not just the headline inflation number.
Helix is the flagship application on Injective and the main reason the burn auction has anything to burn. It is a fully on-chain DEX with a central limit order book, spot markets, and perpetual futures. The order book runs natively in the chain rather than as a contract layer, which is what gives Helix tight spreads and CEX-style execution while still settling on-chain. Most retail Injective volume routes through it.
The wider ecosystem fills in around Helix:
Validator infrastructure is broad. Google Cloud runs an Injective validator, alongside the usual Cosmos-ecosystem operators. Major investors and partners include Binance Labs, Pantera, Jump Crypto, and Mark Cuban. BlackRock’s BUIDL fund has been bridged to Injective, which is the kind of integration you tend not to see on every L1.
iAssets are Injective’s tokenized real-world assets. The category covers tokenized equities, treasury products, and commodities, all priced and traded on-chain through the existing order book modules. Helix offers perpetual futures on US tech names like AAPL and NVDA, plus exposure to gold and short-dated treasuries. The point of the design is that anyone with a wallet can trade these markets without a brokerage account or a stock-trading session schedule.
BlackRock’s BUIDL, a tokenized money-market product, has been bridged to Injective. That gave Injective DeFi protocols access to a yield-bearing dollar primitive backed by short-term US treasuries. iAssets running on top of BUIDL or similar collateral let traders hold a stable yield position and use it as margin for perp positions in the same wallet, which is hard to do in traditional finance.
The catch is regulatory. Tokenized US equities sit in a grey zone in many jurisdictions, and access to perpetual futures on stocks is restricted for retail users in the US, the UK, and the EU. Geo-restrictions on Helix reflect that. The thesis is that the legal picture clarifies over the next few years; the risk is that it tightens instead.
INJ is widely listed, so the buying part is easy. Custody and staking are where the choices that actually affect long-run returns happen.
Send a small test transaction first when moving size. INJ transfers are cheap and fast, but a misrouted send to the wrong network is permanent.
INJ is a bet on derivatives volume on a single chain. Three risks dominate the picture: dependence on trading flow, ecosystem concentration around one application, and the regulatory exposure that comes with tokenized real-world assets.
For longer-term scenarios on INJ specifically, see our Injective price forecast.
This page is information, not financial advice. Talk to someone licensed before allocating real capital.
At the time of writing, Injective (INJ) trades at $5.32, with a 24-hour trading volume of $181.26M and a total market capitalization of $532.43M. The asset is currently ranked #101 among all tracked cryptocurrencies by market cap.
Over the last 24 hours, the INJ price has rose +3.41%. On the seven-day chart, Injective has climbed +12.18%, showing consistent upward momentum across both timeframes. Short-term price swings are often amplified by liquidity conditions, news flow, and derivatives positioning, so traders should confirm signals across multiple indicators before acting.
Injective's all-time high of $52.62 was set on March 14, 2024. The current market price is +89.86% below that historical peak. Distance from the all-time high is a common reference point when evaluating long-term recoveries and identifying macro support or resistance levels.
Buying Injective (INJ) is straightforward once you know which exchange to use and which trading pair offers the best liquidity. The steps below describe the typical flow used by most investors today.
You can also use the built-in Injective converter above to estimate exactly how much INJ you would receive for a given amount in USD before placing an order.
Whether Injective is a good investment depends on your goals, time horizon, and tolerance for volatility. Like all cryptocurrencies, INJ carries significant market risk — prices can rise or fall sharply in a single day, and past performance is not a reliable indicator of future returns.
This page provides data and analysis for educational purposes only. It is not financial advice. Always do your own research, diversify, and never invest more than you can afford to lose.